NOF AMERICA CORPORATION Email Format
Chemical ManufacturingUnited States11-50 Employees
NOF CORPORATION, established in 1937, is a chemical manufacturer pursues multi-faced business developments, focusing on the fields of "Life/Healthcare", "Environment/Energy" and "Electronics/IT". NOF AMERICA CORPORATION, a subsidiary of NOF CORPORATION, provides excellent services to customers for a diversity of products throughout North and South America. As the Life Science fields, we specialize in the development of drug delivery technology and products for next-generation pharmaceuticals, and have been supplying GMP materials for many years; e.g. activated polyethylene glycols(PEGs), functional lipids and pharmaceutical excipients. In accordance with GMP guidelines, our facility ensures the highest standards of quality and safety and supply of the reliable products as pharmaceutical raw materials. NOF's activated PEGs have been utilized in many of the PEGylated drugs marketed worldwide. We also develop innovative products, such as Releasable PEGs enabling to release a native drug in the body with tunable release rate. Our cutting-edge technology "COATSOME SS series", specialized ionizable lipids and LNP platforms, enables high encapsulation, enhanced gene expression and ensuring targeted delivery, all while maintaining the highest safety. We have demonstrated many applications, such as ex-vivo and in-vivo siRNA/mRNA/DNA delivery along with safety data that reveals better performance than conventional LNPs. The additional application provides mRNA based vaccines. Our key materials are; 1. Activated PEGs 2. Functional Lipids 3. Ultrapure Polysorbate 80 4. Biocompatible Materials (MPC) #1 – 3: https://www.nofamerica.com/store/drug-delivery-products.html #4: https://www.nofamerica.com/store/life-science-products.html As a pioneering force in the Life Sciences industry, we are dedicated to pushing the boundaries of drug delivery technology including innovative lipids and PEG derivatives to revolutionize the efficacy and safety of pharmaceutical interventions.